Our Projects
Insights for Success
Innovative Solutions
Our thorough analysis of clinical trials offers valuable insights for your business strategies.
We specialize in analyzing biological data to offer innovative solutions for risk mitigation and investments.
Risk Mitigation
Our expertise in developing investment strategies ensures effective risk mitigation for your ventures. Our detailed data analysis transforms complex information into valuable insights for strategic decision-making.
Biovantage Research's core mission is to arm investors with the knowledge they need to succeed: clear, concise intelligence on drug development programs and clinical trial progress. This empowers them to navigate the complexities of biotech with confidence, making strategic choices and effectively mitigating risk.
BioVantage Research is led by Dr. Geoffrey Girnun, Ph.D., its founder and chief research officer. Geoffrey is a seasoned expert who spent decades at the vanguard of academic research, publishing dozens of high impact manuscripts in oncology and metabolism. Today, Geoffrey channels that unparalleled scientific expertise into the biotech investment landscape.
Outside of his vital work in biotech, Geoffrey is a fervent advocate for scientific literacy, eager to share the awe and beauty of scientific discovery with anyone curious enough to listen
About us
